Annual Drug Patent Expirations for ORSERDU
Orserdu is a drug marketed by Stemline Therap and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has thirty-two patent family members in nineteen countries.
The generic ingredient in ORSERDU is elacestrant dihydrochloride. One supplier is listed for this compound. Additional details are available on the elacestrant dihydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
